EP Patent

EP2578260A1 — Apparatus for intraocular injection

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2013-04-10 · 13y expired

What this patent protects

Described is an apparatus for intraocular injection comprising a body (50) adapted to accommodate a syringe (52) having a needle (54), an outer sleeve (57) telescopically coupled to the body (10), and at least two arms (61) hingedly coupled to the outer sleeve (57). Each of the a…

USPTO Abstract

Described is an apparatus for intraocular injection comprising a body (50) adapted to accommodate a syringe (52) having a needle (54), an outer sleeve (57) telescopically coupled to the body (10), and at least two arms (61) hingedly coupled to the outer sleeve (57). Each of the arms (61) comprises a medial portion (65) adapted to encase at least a portion of the needle (54). When the body (50) moves distally relative to said outer sleeve (57), the body (50) engages the arms (61) separating the medial portions (65).

Drugs covered by this patent

Patent Metadata

Patent number
EP2578260A1
Jurisdiction
EP
Classification
—
Expires
2013-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.